Related references
Note: Only part of the references are listed.Autoinhibition can identify rare driver mutations and advise pharmacology
Ruth Nussinov et al.
FASEB JOURNAL (2020)
Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerization
Nicholas P. D. Liau et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases
Khuchtumur Bum-Erdene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Inhibitors of BRAF dimers using an allosteric site
Xiomaris M. Cotto-Rios et al.
NATURE COMMUNICATIONS (2020)
The current understanding of KRAS protein structure and dynamics
Tatu Pantsar
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
Ruth Nussinov et al.
SEMINARS IN CANCER BIOLOGY (2019)
Ras-Mediated Activation of the Raf Family K nases
Elizabeth M. Terrell et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Targeting Alterations in the RAF-MEK Pathway
Rona Yaeger et al.
CANCER DISCOVERY (2019)
Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases
Yasushi Kondo et al.
SCIENCE (2019)
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes
Eunyoung Park et al.
NATURE (2019)
Does Ras Activate Raf and PI3K Allosterically?
Ruth Nussinov et al.
FRONTIERS IN ONCOLOGY (2019)
Current Insights of BRAF Inhibitors in Cancer
Bogos Agianian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling
Shuai Li et al.
STRUCTURE (2018)
Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain
Timothy Travers et al.
SCIENTIFIC REPORTS (2018)
Allosteric activation of RAF in the MAPK signaling pathway
Chung-Jung Tsai et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Targeting oncogenic Raf protein-serine/threonine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2018)
Protein-Protein Interactions: Emerging Oncotargets in the RAS-ERK Pathway
Rocio Garcia-Gomez et al.
TRENDS IN CANCER (2018)
Targeting the Raf kinases in human cancer: the Raf dimer dilemma
David E. Durrant et al.
BRITISH JOURNAL OF CANCER (2018)
New perspectives for targeting RAF kinase in human cancer
Zoi Karoulia et al.
NATURE REVIEWS CANCER (2017)
Intrinsic protein disorder in oncogenic KRAS signaling
Ruth Nussinov et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
B-Raf activation loop phosphorylation revisited
Martin Koehler et al.
CELL CYCLE (2016)
Ras Conformational Ensembles, Allostery, and Signaling
Shaoyong Lu et al.
CHEMICAL REVIEWS (2016)
Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Shaoyong Lu et al.
CHEMICAL SOCIETY REVIEWS (2016)
Regulation of RAF protein kinases in ERK signalling
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
Susan K. Fetics et al.
STRUCTURE (2015)
Oligomerization and nanocluster organization render specificity
Ruth Nussinov et al.
BIOLOGICAL REVIEWS (2015)
Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation
Neroshan Thevakumaran et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
Kinases and Pseudokinases: Lessons from RAF
Andrey S. Shaw et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling
David Romano et al.
NATURE CELL BIOLOGY (2014)
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase
Yibing Shan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers
Jiancheng Hu et al.
CELL (2013)
Phosphorylation of BRAF by AMPK Impairs BRAF-KSR1 Association and Cell Proliferation
Che-Hung Shen et al.
MOLECULAR CELL (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
Georgia Hatzivassiliou et al.
NATURE (2013)
Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization
Hugo Lavoie et al.
NATURE CHEMICAL BIOLOGY (2013)
Impaired Binding of 14-3-3 to C-RAF in Noonan Syndrome Suggests New Approaches in Diseases with Increased Ras Signaling
Manuela Molzan et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
A dimerization-dependent mechanism drives RAF catalytic activation
Thanashan Rajakulendran et al.
NATURE (2009)
Regulation and role of Raf-1/B-Raf heterodimerization
LK Rushworth et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: A comparison of the X-ray crystal structures of all human 14-3-3 isoforms
Alexandra K. Gardino et al.
SEMINARS IN CANCER BIOLOGY (2006)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
B-Raf and Raf-1 are regulated by distinct autoregulatory mechanisms
NH Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Regulation of Raf through phosphorylation and N terminus-C terminus interaction
HR Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259
AS Dhillon et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
BH Zhang et al.
EMBO JOURNAL (2000)
Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation
D Abraham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
